15 years of revenue, profit, cash flow and balance-sheet history through FY2025, from SEC filings — with a computed, factual read of the trend. Updated Overview →
| FY | Revenue | Net income | Gross M | Op M | FCF | Total debt | Cash |
|---|---|---|---|---|---|---|---|
| 2025 | $10.1B | $2.9B | 66.0% | 29.3% | $2.5B | — | $3.4B |
| 2024 | $8.4B | $2.3B | 67.5% | 28.1% | $1.3B | — | $2.0B |
| 2023 | $7.1B | $1.8B | 66.4% | 24.8% | $750M | — | $2.8B |
| 2022 | $6.2B | $1.3B | 67.4% | 25.3% | $958M | — | $1.6B |
| 2021 | $5.7B | $1.7B | 69.3% | 31.9% | $1.7B | — | $1.3B |
| 2020 | $4.4B | $1.1B | 65.6% | 24.1% | $1.1B | — | $1.6B |
| 2019 | $4.5B | $1.4B | 69.4% | 30.7% | $1.2B | — | $1.2B |
| 2018 | $3.7B | $1.1B | 69.9% | 32.2% | $982M | — | $858M |
| 2017 | $3.1B | $671M | 70.2% | 33.9% | $953M | — | $648M |
| 2016 | $2.7B | $738M | 69.9% | 35.1% | $1.0B | — | $1.0B |
| 2015 | — | $589M | — | — | $725M | — | $715M |
| 2014 | — | $419M | — | — | $560M | — | $600M |
| 2013 | — | $671M | — | — | $775M | — | $782M |
| 2012 | — | $657M | — | — | $700M | — | $554M |
| 2011 | — | $495M | — | — | $595M | — | $466M |
| Quarter | Revenue | Net income | Gross M | Op M | FCF | Total debt | Cash |
|---|---|---|---|---|---|---|---|
| Mar '26 | $2.8B | $822M | 66.1% | 30.9% | $809M | — | $2.0B |
| Dec '25 | $2.9B | $795M | 66.4% | 30.2% | $730M | — | $3.4B |
| Sep '25 | $2.5B | $704M | 66.4% | 30.3% | $736M | — | $2.8B |
| Jun '25 | $2.4B | $658M | 66.3% | 30.5% | $560M | — | $3.4B |
| Mar '25 | $2.3B | $698M | 64.7% | 25.7% | $465M | — | $2.6B |
| Dec '24 | $2.4B | $686M | 68.0% | 30.4% | $511M | — | $2.0B |
| Sep '24 | $2.0B | $565M | 67.4% | 28.3% | $459M | — | $2.4B |
| Jun '24 | $2.0B | $527M | 68.3% | 28.2% | $311M | — | $3.0B |
| Mar '24 | $1.9B | $545M | 65.9% | 24.8% | $24M | — | $2.8B |
| Dec '23 | $1.9B | $606M | 66.2% | 23.3% | -$207M | — | $2.8B |
| Sep '23 | $1.7B | $416M | 66.9% | 26.7% | $292M | — | $3.6B |
| Jun '23 | $1.8B | $421M | 66.7% | 26.4% | $487M | — | $3.4B |
| Mar '23 | $1.7B | $355M | 65.6% | 22.9% | $177M | — | $2.1B |
| Dec '22 | $1.7B | $325M | 67.1% | 22.5% | $299M | — | $1.6B |
| Sep '22 | $1.6B | $324M | 67.6% | 25.6% | $214M | — | $1.5B |
| Jun '22 | $1.5B | $308M | 67.2% | 26.1% | $316M | — | $1.5B |
| Mar '22 | $1.5B | $366M | 67.9% | 27.4% | $129M | — | $1.1B |
| Dec '21 | $1.6B | $381M | 68.4% | 29.0% | $431M | — | $1.3B |
| Sep '21 | $1.4B | $381M | 69.2% | 31.5% | $433M | — | $1.3B |
| Jun '21 | $1.5B | $517M | 69.9% | 34.9% | $467M | — | $1.6B |
How the market has priced ISRG against its own fundamentals since 2023-03 — each month-end's share price set against the most recent annual filing, so the multiple moves as price runs ahead of (or behind) earnings. Split-adjusted.
Over the past 5 years, Intuitive Surgical's revenue has grown 18.2% per year, and net income grown 21.9% per year. These are computed facts, not advice.
As of FY2025, Intuitive Surgical reported — of total debt against $3.4B of cash.
In FY2025, gross margin was 66.0%, operating margin 29.3%, and net margin 28.4%.
As of Jun '26, Intuitive Surgical traded at a price-to-earnings ratio of about 49.5× (market cap ÷ latest annual net income). The valuation charts above show how its P/E, P/S have moved with the share price. These are computed facts, not advice.
All figures are extracted from the company’s SEC EDGAR/XBRL filings — 10-K annual reports and 10-Q quarterly reports (use the Annual / Quarterly toggle). Quarterly figures are derived from the as-filed statements (year-to-date amounts are differenced into discrete quarters). Growth rates and ratios are computed by tradmap; nothing here is investment advice.
Source: SEC EDGAR / XBRL (10-K + 10-Q filings) · prices EOD (Databento), corporate-action-adjusted · growth rates, valuation multiples & ratios computed by tradmap. Valuation uses each month-end price against the latest annual filing. Informational only — not investment advice.